$48.07
+2.05 (+4.45%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+68.73%
1Y
+64.29%
YTD
+70.10%
Open$46.00
Previous Close$46.02
Day High$48.32
Day Low$45.47
52W High$45.76
52W Low$25.17
Volume—
Avg Volume2.30M
Market Cap7.50B
P/E Ratio49.10
EPS$0.90
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$31.02
Above
SMA 200
$29.87
Above
RSI (14)
32.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+162.9% upside
Current
$48.07
$48.07
Target
$126.40
$126.40
$90.34
$126.40 avg
$146.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.46B | 1.33B | 1.89B |
| Net Income | 238.70M | 195.47M | 267.01M |
| Profit Margin | 16.4% | 15.6% | 14.1% |
| EBITDA | 256.38M | 221.62M | 438.15M |
| Free Cash Flow | — | — | 233.31M |
| Rev Growth | +9.9% | +9.9% | +6.3% |
| Debt/Equity | — | — | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |